Skip to content

← All stories

Markets

UBS cuts DiaSorin as Roche competition challenges growth outlook

1 source ·1 article ·2h ago UBS

Covered by 1 outlet

All coverage · 1 article

Investing.com Stock Market ·2h ago

UBS cuts DiaSorin as Roche competition challenges growth outlook